Stifel Financial
DNLI icon

Stifel Financial’s Denali Therapeutics DNLI Stock Holding History

Stifel Financial’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,839
Closed -$287K – 3406
2024
Q3 		$287K Sell
9,839
-3,008
-23% -$74.6K ﹤0.01% 2987
2024
Q2 		$298K Sell
12,847
-26
-0.2% -$499 ﹤0.01% 2919
2024
Q1 		$264K Sell
12,873
-22
-0.2% -$413 ﹤0.01% 2977
2023
Q4 		$277K Buy
12,895
+541
+4% +$10.7K ﹤0.01% 2894
2023
Q3 		$255K Sell
12,354
-905
-7% -$23K ﹤0.01% 2873
2023
Q2 		$391K Sell
13,259
-268
-2% -$7.54K ﹤0.01% 2674
2023
Q1 		$312K Buy
13,527
+120
+0.9% +$3.3K ﹤0.01% 2789
2022
Q4 		$373K Sell
13,407
-141
-1% -$4.2K ﹤0.01% 2636
2022
Q3 		$415K Buy
13,548
+558
+4% +$18.1K ﹤0.01% 2548
2022
Q2 		$383K Sell
12,990
-650
-5% -$17K ﹤0.01% 2618
2022
Q1 		$439K Sell
13,640
-15
-0.1% -$516 ﹤0.01% 2646
2021
Q4 		$609K Sell
13,655
-1,012
-7% -$47.9K ﹤0.01% 2482
2021
Q3 		$740K Buy
14,667
+1,617
+12% +$91.1K ﹤0.01% 2314
2021
Q2 		$1.02M Buy
13,050
+84
+0.6% +$5.2K ﹤0.01% 2077
2021
Q1 		$740K Buy
12,966
+6,955
+116% +$466K ﹤0.01% 2201
2020
Q4 		$503K Sell
6,011
-260
-4% -$15.7K ﹤0.01% 2312
2020
Q3 		$225K Buy
+6,271
New +$189K ﹤0.01% 2558
2020
Q2 		– Sell
-13,621
Closed -$236K – 2871
2020
Q1 		$236K Buy
13,621
+1,726
+15% +$36K ﹤0.01% 2344
2019
Q4 		$207K Buy
11,895
+320
+3% +$5.33K ﹤0.01% 2747
2019
Q3 		$178K Hold
11,575
– – ﹤0.01% 2677
2019
Q2 		$240K Buy
+11,575
New +$259K ﹤0.01% 2622

Other funds holding DNLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Stifel Financial's DNLI Position: Q4 2024 in Review

Stifel Financial sold out of Denali Therapeutics (DNLI) in Q4 2024, closing a stake of 9,839 shares — an estimated $287K sold.

Stifel Financial first reported a position in DNLI in Q2 2019 and held it in 21 quarters. The position peaked at $1.02M in Q2 2021. 223 funds tracked by Wall St. Rank hold DNLI as of Q4 2024.

  • Stifel Financial reported no remaining Denali Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Stifel Financial sold 9,839 Denali Therapeutics shares in Q4 2024, an estimated $287K.
  • Stifel Financial first reported a position in Denali Therapeutics in Q2 2019 and held it in 21 quarters.
  • Stifel Financial's Denali Therapeutics position peaked at $1.02M in Q2 2021.
  • 223 funds tracked by Wall St. Rank held Denali Therapeutics as of Q4 2024.

Based on Stifel Financial's 13F filing for Q4 2024, filed 13 Feb 2025.